The new Radiation Research and Translational Biology, (RRTB) program integrates elements from threeprior Kimmel Cancer Center programs: Structural Biology and Bioinformatics Program, DevelopmentalTherapeutics Program, and Hematological Malignancies and Stem Cell Transplantation Program. Thisrestructuring was undertaken to leverage key strengths of clinical research at the KCC in RadiationOncology, Hematological Malignancies, and Stem Cell Transplantation to create a program that conductsbench to bedside research with sustained return of clinical data to the bench in the form of reversetranslation. The central themes of the new program include angiogenesis, stem cell function andmicroenvironmental mediators of the radiation response. The RRTB is an interdisciplinary programcomprised of basic, translational and clinical investigators from eight departments and multiple areas ofactive investigation, interest and expertise. Their work is supported by $18 million in peer-reviewed funding($16.0 M from NCI). The total number of publications of Program members is 940 of which 16% areIntraprogrammmatic and 14% are Interprogrammatic. The program is a multidisciplinary effort with the goalof defining fundamental mechanisms and targets in radiation research and translational biology, which canfacilitate innovations in treating cancer in patients. The specific goals of the RRTB Program are: (1) Defineand characterize molecular targets for ionizing radiation. (2) Hypoxia and Angiogenesis: Elucidatemechanisms regulating HIF, integrate angiogenesis inhibitors with ionizing radiation and preclinical andclinical imaging of angiogenesis. (3) Study normal tissue injury/genotoxic stress. (4) Understand radiationtarget elucidation and modification and (5) Discover and translate diagnostic and therapeutic innovationsdeveloped in the laboratories of KCC members to clinical practice. This new program has generated newcollaborations within the program and fresh research directions with other research programs in the cancercenter.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA056036-09
Application #
7712908
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-09-05
Project End
2013-05-31
Budget Start
2008-09-05
Budget End
2009-05-31
Support Year
9
Fiscal Year
2008
Total Cost
$20,798
Indirect Cost
Name
Thomas Jefferson University
Department
Type
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Heeke, Arielle L; Pishvaian, Michael J; Lynce, Filipa et al. (2018) Prevalence of Homologous Recombination-Related Gene Mutations Across Multiple Cancer Types. JCO Precis Oncol 2018:
Parent, Kristin N; Schrad, Jason R; Cingolani, Gino (2018) Breaking Symmetry in Viral Icosahedral Capsids as Seen through the Lenses of X-ray Crystallography and Cryo-Electron Microscopy. Viruses 10:
Rappaport, Jeffrey A; Waldman, Scott A (2018) The Guanylate Cyclase C-cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia. Front Oncol 8:299
Pandya, Kalgi D; Palomo-Caturla, Isabel; Walker, Justin A et al. (2018) An Unmutated IgM Response to the Vi Polysaccharide of Salmonella Typhi Contributes to Protective Immunity in a Murine Model of Typhoid. J Immunol 200:4078-4084
Hussain, Maha; Daignault-Newton, Stephanie; Twardowski, Przemyslaw W et al. (2018) Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012. J Clin Oncol 36:991-999
Shafi, Ayesha A; Schiewer, Matthew J; de Leeuw, Renée et al. (2018) Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response. Eur Urol Oncol 1:325-337
Meyer, Sara E; Muench, David E; Rogers, Andrew M et al. (2018) miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential. J Exp Med 215:2115-2136
Mazina, Olga M; Mazin, Alexander V (2018) Reconstituting the 4-Strand DNA Strand Exchange. Methods Enzymol 600:285-305
Magee, Michael S; Abraham, Tara S; Baybutt, Trevor R et al. (2018) Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases. Cancer Immunol Res 6:509-516
Chervoneva, Inna; Freydin, Boris; Hyslop, Terry et al. (2018) Modeling qRT-PCR dynamics with application to cancer biomarker quantification. Stat Methods Med Res 27:2581-2595

Showing the most recent 10 out of 807 publications